NCT02954601View on ClinicalTrials.gov

A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

February 24, 2017

Study Completion Date

March 15, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

ORMD-0801 (qd)

Dose 1 = ORMD-0801 (qd)

DRUG

ORMD-0801 (bid)

Dose 2 = ORMD-0801 (bid)

DRUG

ORMD-0801 (tid)

Dose 3 = ORMD-0801 (tid)

OTHER

Placebo

fish oil placebo

Trial Locations (1)

92780

Orange County Research Center, Tustin

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Integrium

INDUSTRY

lead

Oramed, Ltd.

INDUSTRY